Dataset Viewer
Auto-converted to Parquet Duplicate
form_type
stringclasses
2 values
accession_number
stringlengths
20
20
filing_date
stringlengths
14
14
quarter_ending
stringclasses
172 values
company_name
stringlengths
5
54
text
stringlengths
101
2.42k
entities
listlengths
1
18
10-Q
0000897101-17-001458
20171113161331
20170930
Ben Franklin Financial, Inc.
The Company has incurred losses since 2008 resulting from a combination of: declining net interest income, as our loan portfolio decreased from $109.8 million at December 31, 2008 to $62.3 million at December 31, 2016; increased provisions for loan losses between 2009 and 2012; and increasing non-interest expense relat...
[ { "currency_/_unit": "USD", "end_character": 150, "end_date_for_period": "2008-12-31", "label": "XBRL-OOS", "start_character": 145, "start_date_for_period": "2008-12-31", "value": 109800000 }, { "currency_/_unit": "USD", "end_character": 188, "end_date_for_period": "2016-...
10-K
0000014846-18-000041
20181210173253
20180930
BRT Apartments Corp.
Certain items on the consolidated financial statements for the prior years have been reclassified to conform with the current year's presentation, including the reclassification (i) of the operations and related assets of the Newark Joint Venture to discontinued operations, (ii) of deferred loan costs on the consolidat...
[ { "currency_/_unit": "USD", "end_character": 648, "end_date_for_period": "2016-09-30", "label": "revenues", "start_character": 639, "start_date_for_period": "2015-10-01", "value": 4066000 } ]
10-K
0000014846-18-000041
20181210173253
20180930
BRT Apartments Corp.
(a) Includes Waverly Place, Melbourne FL, sold on October 25, 2017, Valley Venue, Valley, AL, sold on February 23, 2018 and Garden Square, Palm Beach Gardens, FL sold on February 25, 2018. These properties in total had 1,368 units and accounted for $5,815 of 2018 revenues.
[ { "currency_/_unit": "brt:property_unit", "end_character": 224, "end_date_for_period": "2018-09-30", "label": "XBRL-OOS", "start_character": 219, "start_date_for_period": "2018-09-30", "value": 1368 }, { "currency_/_unit": "USD", "end_character": 255, "end_date_for_period...
10-Q
0000014846-18-000033
20180808164128
20180630
BRT Apartments Corp.
For the three months ended June 30, 2018, no shares were included as their effect would have been anti-dilutive.
[ { "currency_/_unit": "shares", "end_character": 44, "end_date_for_period": "2018-06-30", "label": "eps", "start_character": 42, "start_date_for_period": "2018-04-01", "value": 0 } ]
10-Q
0001084991-18-000049
20180809151800
20180630
NATURAL GAS SERVICES GROUP INC
From time to time, upon the customer’s written request, we recognize revenue when manufacturing is complete and the equipment is ready for shipment. At the customer’s request, we will bill the customer upon completing all performance obligations, but before shipment. The customer will formally request we ship the equip...
[ { "currency_/_unit": "USD", "end_character": 1158, "end_date_for_period": "2018-06-30", "label": "revenues", "start_character": 1155, "start_date_for_period": "2018-01-01", "value": 6300000 } ]
10-Q
0001068875-18-000057
20180801064736
20180630
BLUCORA, INC.
As a result of the ASC 606 adoption, the Company now recognizes certain licensing fees on a net basis, which reduced both transaction and fee revenues and operating expenses by $0.4 million and $0.9 million, respectively, for the three and six months ended June 30, 2018, on the consolidated statements of comprehensive ...
[ { "currency_/_unit": "USD", "end_character": 181, "end_date_for_period": "2018-06-30", "label": "revenues", "start_character": 178, "start_date_for_period": "2018-04-01", "value": -400000 }, { "currency_/_unit": "USD", "end_character": 198, "end_date_for_period": "2018-06...
10-Q
0001610466-18-000069
20181102102143
20180930
Shell Midstream Partners, L.P.
Our interest in Amberjack was acquired on May 11, 2018. Amberjack total revenues, total operating expenses and operating income (on a 100% basis) was $214.0 million, $53.8 million and $160.2 million, respectively. 
[ { "currency_/_unit": "USD", "end_character": 156, "end_date_for_period": "2018-09-30", "label": "revenues", "start_character": 151, "start_date_for_period": "2018-01-01", "value": 214000000 }, { "currency_/_unit": "USD", "end_character": 171, "end_date_for_period": "2018-...
10-Q
0001125345-18-000097
20181107160542
20180930
MACROGENICS INC
The Company also has an agreement with Incyte under which the Company is to perform manufacturing services for Incyte’s clinical needs of MGA012. The Company evaluated the agreement under ASC 606 and identified one performance obligation under the agreement - to perform services related to manufacturing the clinical s...
[ { "currency_/_unit": "USD", "end_character": 782, "end_date_for_period": "2018-09-30", "label": "revenues", "start_character": 779, "start_date_for_period": "2018-07-01", "value": 6100000 }, { "currency_/_unit": "USD", "end_character": 800, "end_date_for_period": "2018-09...
10-Q
0001125345-18-000097
20181107160542
20180930
MACROGENICS INC
Revenue associated with each performance obligation is being recognized as the research and development services are provided using an input method according to research and development costs incurred to date compared to estimated total research and development costs. The transfer of control occurs over this time perio...
[ { "currency_/_unit": "USD", "end_character": 1128, "end_date_for_period": "2018-09-30", "label": "revenues", "start_character": 1125, "start_date_for_period": "2018-07-01", "value": 500000 }, { "currency_/_unit": "USD", "end_character": 1145, "end_date_for_period": "2018-...
10-Q
0001125345-18-000097
20181107160542
20180930
MACROGENICS INC
The Company recognized revenue of $6.1 million when it satisfied its performance obligations and transferred the MGD010 license and teplizumab assets to Provention during May 2018. The warrants are reported in other assets on the balance sheet at September 30, 2018, and there was no material change in the valuation of...
[ { "currency_/_unit": "USD", "end_character": 38, "end_date_for_period": "2018-09-30", "label": "revenues", "start_character": 35, "start_date_for_period": "2018-07-01", "value": 6100000 } ]
10-Q
0000930420-18-000276
20181101163217
20180930
KFORCE INC
For the three and nine months ended September 30, 2018, there were 635 thousand and 505 thousand common stock equivalents included in the diluted WASO, respectively. For the three and nine months ended September 30, 2017, there were 239 thousand and 301 thousand common stock equivalents included in the diluted WASO, re...
[ { "currency_/_unit": "shares", "end_character": 70, "end_date_for_period": "2018-09-30", "label": "eps", "start_character": 67, "start_date_for_period": "2018-07-01", "value": 635000 }, { "currency_/_unit": "shares", "end_character": 87, "end_date_for_period": "2018-09-30...
10-Q
0001125920-18-000020
20181107172437
20180930
SHUTTERFLY INC
, the Company settled the principal of the convertible senior notes in cash upon their maturity in May 2018. The weighted-average impact to dilution for the period that the conversion option was outstanding was 451,000 shares for the nine months ended September 30, 2018. The potential conversion impact was excluded fro...
[ { "currency_/_unit": "shares", "end_character": 218, "end_date_for_period": "2018-09-30", "label": "eps", "start_character": 211, "start_date_for_period": "2018-01-01", "value": 451000000 } ]
10-Q
0001084991-18-000059
20181109155024
20180930
NATURAL GAS SERVICES GROUP INC
From time to time, upon the customer’s written request, we recognize revenue when manufacturing is complete and the equipment is ready for shipment. At the customer’s request, we will bill the customer upon completing all performance obligations, but before shipment. The customer will formally request we ship the equip...
[ { "currency_/_unit": "USD", "end_character": 1169, "end_date_for_period": "2018-09-30", "label": "revenues", "start_character": 1166, "start_date_for_period": "2018-01-01", "value": 7600000 } ]
10-Q
0001595974-18-000110
20181107184726
20180930
RUBICON PROJECT, INC.
The Company has determined that it does not act as the principal in the purchase and sale of digital advertising inventory because it does not have control of the digital advertising inventory and does not set prices agreed upon within the auction marketplace, and therefore reports revenue on a net basis. In periods pr...
[ { "currency_/_unit": "USD", "end_character": 850, "end_date_for_period": "2017-09-30", "label": "revenues", "start_character": 847, "start_date_for_period": "2017-01-01", "value": 1300000 } ]
10-K
0001336917-19-000011
20190222185511
20181231
Under Armour, Inc.
The Company identified an immaterial prior period error in the presentation of premium subscriptions in its Connected Fitness reporting segment. Subscription revenue was previously recorded net of any related commission. Beginning in the first quarter of 2018, subscription revenue is recorded on a gross basis and the r...
[ { "currency_/_unit": "USD", "end_character": 642, "end_date_for_period": "2017-12-31", "label": "revenues", "start_character": 638, "start_date_for_period": "2017-01-01", "value": 12700000 }, { "currency_/_unit": "USD", "end_character": 659, "end_date_for_period": "2016-1...
10-K
0001336917-19-000011
20190222185511
20181231
Under Armour, Inc.
In addition to the investment in Dome, the Company has a license agreement with Dome. The Company recorded license revenues from Dome of $35.6 million for the year ended December 31, 2018. As of December 31, 2018, the Company has $13.1 million in licensing receivables outstanding, recorded in the prepaid expenses and o...
[ { "currency_/_unit": "USD", "end_character": 142, "end_date_for_period": "2018-12-31", "label": "revenues", "start_character": 138, "start_date_for_period": "2018-01-01", "value": 35600000 }, { "currency_/_unit": "USD", "end_character": 235, "end_date_for_period": "2018-1...
10-K
0001336917-19-000011
20190222185511
20181231
Under Armour, Inc.
As of December 31, 2018, approximately $165.1 million of cash and cash equivalents was held by the Company's non-U.S. subsidiaries whose cumulative undistributed earnings total $633.6 million. The majority of these earnings were subject to U.S. federal income tax as part of the one-time transition tax on indefinitely r...
[ { "currency_/_unit": "USD", "end_character": 45, "end_date_for_period": "2018-12-31", "label": "XBRL-OOS", "start_character": 40, "start_date_for_period": "2018-12-31", "value": 165100000 }, { "currency_/_unit": "USD", "end_character": 183, "end_date_for_period": "2018-12...
10-K
0001336917-19-000011
20190222185511
20181231
Under Armour, Inc.
Net revenues in the United States were $3,464.0 million, $3,626.6 million, and $3,843.7 million for the years ended December 31, 2018, 2017 and 2016, respectively. 
[ { "currency_/_unit": "USD", "end_character": 47, "end_date_for_period": "2018-12-31", "label": "revenues", "start_character": 40, "start_date_for_period": "2018-01-01", "value": 3464000000 }, { "currency_/_unit": "USD", "end_character": 65, "end_date_for_period": "2017-12...
10-K
0001104485-19-000059
20190318083501
20181231
NORTHERN OIL & GAS, INC.
As of December 31, 2018, 2017 and 2016, potentially dilutive shares from stock option awards were zero, 250,000 and 391,872, respectively. The Company also has potentially dilutive shares from restricted stock awards outstanding of 2,827,859, 1,721,533, and 1,905,104 at December 31, 2018, 2017 and 2016, respectively.
[ { "currency_/_unit": "shares", "end_character": 241, "end_date_for_period": "2018-12-31", "label": "eps", "start_character": 232, "start_date_for_period": "2018-01-01", "value": 2827859 }, { "currency_/_unit": "shares", "end_character": 252, "end_date_for_period": "2017-1...
10-K
0001125345-19-000046
20190226161059
20181231
MACROGENICS INC
The Company also has an agreement with Incyte, which was signed in 2018, under which the Company is to perform development and manufacturing services for Incyte’s clinical needs of MGA012. The Company evaluated this agreement under ASC 606 and identified one performance obligation under the agreement - to perform serv...
[ { "currency_/_unit": "USD", "end_character": 809, "end_date_for_period": "2018-12-31", "label": "revenues", "start_character": 805, "start_date_for_period": "2018-01-01", "value": 22200000 } ]
10-K
0001125345-19-000046
20190226161059
20181231
MACROGENICS INC
Revenue associated with each performance obligation is being recognized as the research and development services are provided using an input method according to research and development costs incurred to date compared to estimated total research and development costs. The transfer of control occurs over this time perio...
[ { "currency_/_unit": "USD", "end_character": 1342, "end_date_for_period": "2018-12-31", "label": "revenues", "start_character": 1339, "start_date_for_period": "2018-01-01", "value": 1900000 }, { "currency_/_unit": "USD", "end_character": 1356, "end_date_for_period": "2017...
10-K
0001125345-19-000046
20190226161059
20181231
MACROGENICS INC
The Company recognized revenue of $6.1 million when it satisfied its performance obligations and transferred the MGD010 license and teplizumab assets to Provention in May 2018. The warrants are reported in other assets on the balance sheet at December 31, 2018 and will be revalued at each reporting period until exerci...
[ { "currency_/_unit": "USD", "end_character": 38, "end_date_for_period": "2018-05-31", "label": "revenues", "start_character": 35, "start_date_for_period": "2018-05-01", "value": 6100000 }, { "currency_/_unit": "USD", "end_character": 481, "end_date_for_period": "2018-12-3...
10-K
0001125345-19-000046
20190226161059
20181231
MACROGENICS INC
In May 2016, the Company entered into a collaboration and license agreement with Janssen, a related party through ownership of the Company's common stock, for the development and commercialization of MGD015, a product candidate that incorporates the Company's proprietary DART technology to simultaneously target CD3 and...
[ { "currency_/_unit": "USD", "end_character": 598, "end_date_for_period": "2016-07-31", "label": "XBRL-OOS", "start_character": 594, "start_date_for_period": "2016-07-01", "value": 75000000 }, { "currency_/_unit": "USD", "end_character": 805, "end_date_for_period": "2018-1...
10-K
0000897101-19-000192
20190312110803
20181231
CYBEROPTICS CORP
Revenue from sales of high precision 3D and 2D sensors based on our 3D Multi-Reflection Suppression (MRS) technology was $7.9 million in 2018 and $4.4 million in 2017. Revenue from sales of inspection and metrology systems that incorporate our 3D MRS sensor technology was $13.3 million in 2018 and $10.0 million in 2017...
[ { "currency_/_unit": "USD", "end_character": 125, "end_date_for_period": "2018-12-31", "label": "revenues", "start_character": 122, "start_date_for_period": "2018-01-01", "value": 7900000 }, { "currency_/_unit": "USD", "end_character": 150, "end_date_for_period": "2017-12...
10-K
0000897101-19-000192
20190312110803
20181231
CYBEROPTICS CORP
Revenue from sales of high precision 3D and 2D sensors based on our 3D Multi-Reflection Suppression (MRS) technology was $7.9 million in 2018 and $4.4 million in 2017. Revenue from sales of inspection and metrology systems that incorporate our 3D MRS sensor technology was $13.3 million in 2018 and $10.0 million in 2017...
[ { "currency_/_unit": "USD", "end_character": 125, "end_date_for_period": "2018-12-31", "label": "revenues", "start_character": 122, "start_date_for_period": "2018-01-01", "value": 7900000 }, { "currency_/_unit": "USD", "end_character": 150, "end_date_for_period": "2017-12...
10-K
0000897101-19-000192
20190312110803
20181231
CYBEROPTICS CORP
Revenue from sales of high precision 3D and 2D sensors based on our 3D Multi-Reflection Suppression (MRS) technology was $7.9 million in 2018 and $4.4 million in 2017. Revenue from sales of inspection and metrology systems that incorporate our 3D MRS sensor technology was $13.3 million in 2018 and $10.0 million in 2017...
[ { "currency_/_unit": "USD", "end_character": 125, "end_date_for_period": "2018-12-31", "label": "revenues", "start_character": 122, "start_date_for_period": "2018-01-01", "value": 7900000 }, { "currency_/_unit": "USD", "end_character": 150, "end_date_for_period": "2017-12...
10-K
0000883945-19-000016
20190227171839
20181231
USA TRUCK INC
$41.5 million, $35.5 million, and $36.9 million for the years ended December 31, 2018, 2017 and 2016, respectively.  All foreign revenue is collected in U.S. dollars. 
[ { "currency_/_unit": "USD", "end_character": 5, "end_date_for_period": "2018-12-31", "label": "revenues", "start_character": 1, "start_date_for_period": "2018-01-01", "value": 41500000 }, { "currency_/_unit": "USD", "end_character": 20, "end_date_for_period": "2017-12-31"...
10-K
0000883945-19-000016
20190227171839
20181231
USA TRUCK INC
, and operations were closed during the first quarter of 2018.  Foreign revenue from USAT Logistics de Mexico was $0.8 million and $2.1 million for the years ended December 31, 2018 and 2017, respectively.  All foreign revenue is collected in U.S. dollars.
[ { "currency_/_unit": "USD", "end_character": 118, "end_date_for_period": "2018-12-31", "label": "revenues", "start_character": 115, "start_date_for_period": "2018-01-01", "value": 800000 }, { "currency_/_unit": "USD", "end_character": 135, "end_date_for_period": "2017-12-...
10-K
0001628280-19-002785
20190311191254
20181231
CUMBERLAND PHARMACEUTICALS INC
The Company has one operating segment which is specialty pharmaceutical products. Management has chosen to organize the Company based on the type of products sold. Operating segments are identified as components of an enterprise about which separate discrete financial information is evaluated by the chief operating dec...
[ { "currency_/_unit": "USD", "end_character": 892, "end_date_for_period": "2018-12-31", "label": "revenues", "start_character": 889, "start_date_for_period": "2018-01-01", "value": 2100000 }, { "currency_/_unit": "USD", "end_character": 906, "end_date_for_period": "2017-12...
10-K
0001084991-19-000013
20190318172718
20181231
NATURAL GAS SERVICES GROUP INC
From time to time, upon the customer’s written request, we recognize revenue when manufacturing is complete and the equipment is ready for shipment. At the customer’s request, we will bill the customer upon completing all performance obligations, but before shipment. The customer will formally request we ship the equip...
[ { "currency_/_unit": "USD", "end_character": 1171, "end_date_for_period": "2018-12-31", "label": "revenues", "start_character": 1168, "start_date_for_period": "2018-01-01", "value": 8300000.000000001 }, { "currency_/_unit": "USD", "end_character": 1188, "end_date_for_peri...
10-K
0001439222-19-000004
20190214084837
20181231
AGIOS PHARMACEUTICALS INC
During the year ended December 31, 2018, we recognized $0.2 million as collaboration revenue - other for certain other services provided by us, that were not considered performance obligations as of the inception date of the CStone Agreement.
[ { "currency_/_unit": "USD", "end_character": 59, "end_date_for_period": "2018-12-31", "label": "revenues", "start_character": 56, "start_date_for_period": "2018-01-01", "value": 200000 } ]
10-K
0001628280-19-002990
20190315114104
20181231
WillScot Corp
(c) Historic Acton revenues were $93.9 million and historic ModSpace revenues were $443.5 million, respectively, for the year ended December 31, 2017. Historic Acton pre-tax loss was $3.2 million and historic ModSpace pre-tax loss was $108.1 million, respectively, for the year ended December 31, 2017.
[ { "currency_/_unit": "USD", "end_character": 38, "end_date_for_period": "2017-12-31", "label": "revenues", "start_character": 34, "start_date_for_period": "2017-01-01", "value": 93900000 }, { "currency_/_unit": "USD", "end_character": 89, "end_date_for_period": "2017-12-3...
10-K
0001628280-19-002990
20190315114104
20181231
WillScot Corp
(e) Depreciation of rental equipment and non-rental depreciation were adjusted for the fair value mark-ups of equipment acquired in the Acton and ModSpace acquisitions. For the year ended December 31, 2017, Acton had additional depreciation expense of $5.3 million and ModSpace had a reduction of $18.9 million.
[ { "currency_/_unit": "USD", "end_character": 256, "end_date_for_period": "2017-12-31", "label": "earnings", "start_character": 253, "start_date_for_period": "2017-01-01", "value": 5300000 }, { "currency_/_unit": "USD", "end_character": 302, "end_date_for_period": "2017-12...
10-K
0001628280-19-002990
20190315114104
20181231
WillScot Corp
(i) Interest on Acton and ModSpace historic debt was eliminated. Historic Acton interest was $5.1 million and historic ModSpace interest was $40.4 million, respectively, for the year ended December 31, 2017.
[ { "currency_/_unit": "USD", "end_character": 97, "end_date_for_period": "2017-12-31", "label": "earnings", "start_character": 94, "start_date_for_period": "2017-01-01", "value": 5100000 }, { "currency_/_unit": "USD", "end_character": 146, "end_date_for_period": "2017-12-3...
10-K
0001714973-19-000013
20190219070525
20181231
Kinder Morgan Canada Ltd
Income from continuing operations before income taxes for years ended December 31, 2018, 2017, and 2016 were $137.8 million, $71.3 million, and $93.8 million, respectively.
[ { "currency_/_unit": "CAD", "end_character": 115, "end_date_for_period": "2018-12-31", "label": "earnings", "start_character": 110, "start_date_for_period": "2018-01-01", "value": 137800000 }, { "currency_/_unit": "CAD", "end_character": 130, "end_date_for_period": "2017-...
10-K
0001654948-19-000025
20190416170051
20181231
Hartman vREIT XXI, Inc.
For the years ended December 31, 2018 and 2017, we incurred a net loss of $1,292,229 and $1,537,566, respectively.  We do not anticipate forming any taxable REIT subsidiaries or otherwise generating future taxable income which may be offset by the net loss carry forward.  We consider that any deferred tax benefit and c...
[ { "currency_/_unit": "USD", "end_character": 84, "end_date_for_period": "2018-12-31", "label": "earnings", "start_character": 75, "start_date_for_period": "2018-01-01", "value": -1292229 }, { "currency_/_unit": "USD", "end_character": 99, "end_date_for_period": "2017-12-3...
10-K
0001654948-19-000025
20190416170051
20181231
Hartman vREIT XXI, Inc.
The primary source of our revenue is rental revenues and tenant reimbursements.  Total revenue for the year ended December 31, 2018 was $1,550,246, an increase of approximately $632,000 over the year ended December 31, 2017. The increase is attributable to our ownership of Richardson Tech Center beginning in March, 20...
[ { "currency_/_unit": "USD", "end_character": 146, "end_date_for_period": "2018-12-31", "label": "revenues", "start_character": 137, "start_date_for_period": "2018-01-01", "value": 1550246 } ]
10-K
0001654948-19-000025
20190416170051
20181231
Hartman vREIT XXI, Inc.
For the years ended December 31, 2018 and 2017, the Company incurred a net loss of $1,292,229 and $1,537,566, respectively.  The Company does not anticipate forming any taxable REIT subsidiaries or otherwise generating future taxable income which may be offset by the net loss carry forward.  The Company considers that ...
[ { "currency_/_unit": "USD", "end_character": 93, "end_date_for_period": "2018-12-31", "label": "earnings", "start_character": 84, "start_date_for_period": "2018-01-01", "value": -1292229 }, { "currency_/_unit": "USD", "end_character": 108, "end_date_for_period": "2017-12-...
10-K
0001654948-19-000025
20190416170051
20181231
Hartman vREIT XXI, Inc.
For the years ended December 31, 2018 and 2017, the Company had net loss of $1,292,229 and $1,537,566, respectively. The Company does not anticipate forming any taxable REIT subsidiaries or otherwise generating future taxable income which may be offset by the net loss carry forward.  The Company considers that any defe...
[ { "currency_/_unit": "USD", "end_character": 86, "end_date_for_period": "2018-12-31", "label": "earnings", "start_character": 77, "start_date_for_period": "2018-01-01", "value": -1292229 }, { "currency_/_unit": "USD", "end_character": 101, "end_date_for_period": "2017-12-...
10-K
0001628280-19-003719
20190401160610
20181231
Teligent, Inc.
For the year ended December 31, 2018, domestic net revenues were $45.6 million and foreign net revenues were $20.2 million. As of December 31, 2018, domestic assets were $132.7 million and foreign assets were $58.2 million. For the year ended December 31, 2017, domestic net revenues were $47.0 million and foreign net r...
[ { "currency_/_unit": "USD", "end_character": 70, "end_date_for_period": "2018-12-31", "label": "revenues", "start_character": 66, "start_date_for_period": "2018-01-01", "value": 45600000 }, { "currency_/_unit": "USD", "end_character": 114, "end_date_for_period": "2018-12-...
10-K
0000812128-19-000017
20191219073407
20191031
SANDERSON FARMS INC
Sales of offal are considered by-products; accordingly, these amounts reduce cost of sales and totaled $31.1 million, $34.4 million and $32.6 million in fiscal 2019, 2018 and 2017, respectively.
[ { "currency_/_unit": "USD", "end_character": 108, "end_date_for_period": "2019-10-31", "label": "revenues", "start_character": 104, "start_date_for_period": "2018-11-01", "value": 31100000 }, { "currency_/_unit": "USD", "end_character": 123, "end_date_for_period": "2018-1...
10-K
0000812128-19-000017
20191219073407
20191031
SANDERSON FARMS INC
The Company sells certain of its products either directly to foreign markets or to U.S. based customers who resell the product in foreign markets. These foreign markets for fiscal 2019 and 2018 were primarily Mexico, Cuba, Central Asia and the Middle East, and for fiscal 2017 were primarily Mexico, Central Asia and the...
[ { "currency_/_unit": "USD", "end_character": 418, "end_date_for_period": "2019-10-31", "label": "revenues", "start_character": 413, "start_date_for_period": "2018-11-01", "value": 284500000 }, { "currency_/_unit": "USD", "end_character": 434, "end_date_for_period": "2018-...
10-K
0000350797-19-000065
20191220173027
20191031
EATON VANCE CORP
17.0 million for the years ended October 31, 2018 and 2017, respectively. Lastly, contingent deferred sales charges received, which were previously recorded as a reduction of deferred sales commission assets, are now recorded as revenue within the distribution and underwriting fees line item in the Consolidated Stateme...
[ { "currency_/_unit": "USD", "end_character": 4, "end_date_for_period": "2017-10-31", "label": "revenues", "start_character": 0, "start_date_for_period": "2016-11-01", "value": 17000000 } ]
10-Q
0000014846-19-000021
20190509150919
20190331
BRT Apartments Corp.
Basic earnings (loss) per share is determined by dividing net income (loss) applicable to common stockholders for the applicable period by the weighted average number of shares of common stock outstanding during such period. The Units are excluded from the basic earnings per share calculation, as they are not participa...
[ { "currency_/_unit": "shares", "end_character": 1086, "end_date_for_period": "2018-03-31", "label": "eps", "start_character": 1079, "start_date_for_period": "2018-01-01", "value": 200000 } ]
10-Q
0001277902-19-000024
20190501160902
20190331
MVB FINANCIAL CORP
For the three months ended March 31, 2019, the Commercial & Retail Banking segment earned $4.2 million compared to $3.6 million in 2018. Net interest income increased by $2.4 million, primarily the result of an increase of $4.3 million in interest and fees on loans
[ { "currency_/_unit": "USD", "end_character": 94, "end_date_for_period": "2019-03-31", "label": "earnings", "start_character": 91, "start_date_for_period": "2019-01-01", "value": 4200000 }, { "currency_/_unit": "USD", "end_character": 119, "end_date_for_period": "2018-03-3...
10-Q
0001277902-19-000024
20190501160902
20190331
MVB FINANCIAL CORP
For the three months ended March 31, 2019, the Mortgage Banking segment earned $335 thousand compared to $150 thousand in 2018. Net interest income decreased $63 thousand, which was the result of
[ { "currency_/_unit": "USD", "end_character": 83, "end_date_for_period": "2019-03-31", "label": "earnings", "start_character": 80, "start_date_for_period": "2019-01-01", "value": 335000 }, { "currency_/_unit": "USD", "end_character": 109, "end_date_for_period": "2018-03-31...
10-Q
0001084991-19-000033
20190510122647
20190510
NATURAL GAS SERVICES GROUP INC
From time to time, upon the customer’s written request, we recognize revenue when manufacturing is complete and the equipment is ready for shipment. At the customer’s request, we will bill the customer upon completing all performance obligations, but before shipment. The customer will formally request we ship the equip...
[ { "currency_/_unit": "USD", "end_character": 1166, "end_date_for_period": "2019-03-31", "label": "revenues", "start_character": 1163, "start_date_for_period": "2019-01-01", "value": 2700000 } ]
10-Q
0001336917-19-000037
20190509154227
20190331
Under Armour, Inc.
In addition to the investment in Dome, the Company has a license agreement with Dome. The Company recorded license revenues from Dome of $6.5 million for the three months ended March 31, 2019. As of March 31, 2019
[ { "currency_/_unit": "USD", "end_character": 141, "end_date_for_period": "2019-03-31", "label": "revenues", "start_character": 138, "start_date_for_period": "2019-01-01", "value": 6500000 } ]
10-Q
0001735828-19-000024
20190510160423
20190331
Legacy Reserves Inc.
For the period ended March 31, 2019 and 2018 we recorded income/(loss) before income taxes of $(78,378) and $64,869. respectively. All of Legacy's income is sourced within the United States. The effective combined U.S. federal and state income tax rates were 0% and 0.75% for the three months ended March 31, 2019 and 20...
[ { "currency_/_unit": "USD", "end_character": 102, "end_date_for_period": "2019-03-31", "label": "earnings", "start_character": 96, "start_date_for_period": "2019-01-01", "value": -78378000 }, { "currency_/_unit": "USD", "end_character": 115, "end_date_for_period": "2018-0...
10-Q
0001125345-19-000059
20190501160614
20190331
MACROGENICS INC
The Company also has an agreement with Incyte, which was entered into in 2018, under which the Company is to perform development and manufacturing services for Incyte’s clinical needs of MGA012. The Company evaluated the agreement under ASC 606 and identified one performance obligation under the agreement: to perform ...
[ { "currency_/_unit": "USD", "end_character": 817, "end_date_for_period": "2019-03-31", "label": "revenues", "start_character": 814, "start_date_for_period": "2019-01-01", "value": 4000000 }, { "currency_/_unit": "USD", "end_character": 873, "end_date_for_period": "2018-03...
10-Q
0001125345-19-000059
20190501160614
20190331
MACROGENICS INC
Revenue associated with each performance obligation was recognized as the research and development services were provided using an input method according to research and development costs incurred to date compared to estimated total research and development costs. The transfer of control occurred over this time period ...
[ { "currency_/_unit": "USD", "end_character": 538, "end_date_for_period": "2019-03-31", "label": "revenues", "start_character": 536, "start_date_for_period": "2019-01-01", "value": 0 }, { "currency_/_unit": "USD", "end_character": 642, "end_date_for_period": "2018-03-31", ...
10-Q
0001125345-19-000059
20190501160614
20190331
MACROGENICS INC
Due to the relatively short-term nature of the recognition period, the revenue associated with the MGD013 performance obligation is being recognized on a straight-line basis as the Company performs research and development activities under the agreement. The fixed consideration related to the margetuximab performance ...
[ { "currency_/_unit": "USD", "end_character": 837, "end_date_for_period": "2019-03-31", "label": "revenues", "start_character": 834, "start_date_for_period": "2019-01-01", "value": 4000000 }, { "currency_/_unit": "USD", "end_character": 905, "end_date_for_period": "2019-03...
10-Q
0000930420-19-000122
20190502163725
20190331
KFORCE INC
For the three months ended March 31, 2019 and 2018, there were 503 thousand and 290 thousand common stock equivalents included in the diluted WASO, respectively. For the three months ended March 31, 2019 and 2018, there were insignificant anti-dilutive common stock equivalents.
[ { "currency_/_unit": "shares", "end_character": 66, "end_date_for_period": "2019-03-31", "label": "eps", "start_character": 63, "start_date_for_period": "2019-01-01", "value": 503000 }, { "currency_/_unit": "shares", "end_character": 83, "end_date_for_period": "2018-03-31...
10-Q
0001628280-19-005793
20190503111828
20190331
WillScot Corp
Includes $3.8 million and $2.3 million of VAPS service revenue for the three months ended March 31, 2019 and 2018, respectively.
[ { "currency_/_unit": "USD", "end_character": 13, "end_date_for_period": "2019-03-31", "label": "revenues", "start_character": 10, "start_date_for_period": "2019-01-01", "value": 3800000 }, { "currency_/_unit": "USD", "end_character": 30, "end_date_for_period": "2018-03-31...
10-Q
0001628280-19-006554
20190510160514
20190331
Teligent, Inc.
For the three months ended March 31, 2019, domestic net revenues were $9.7 million and foreign net revenues were $3.4 million. As of March 31, 2019, domestic assets were $135.5 million and foreign assets were $56.4 million. For the three months ended March 31, 2018, domestic net revenues were $10.2 million and foreign ...
[ { "currency_/_unit": "USD", "end_character": 74, "end_date_for_period": "2019-03-31", "label": "revenues", "start_character": 71, "start_date_for_period": "2019-01-01", "value": 9700000 }, { "currency_/_unit": "USD", "end_character": 117, "end_date_for_period": "2019-03-3...
10-Q
0000930420-19-000176
20190801161138
20190630
KFORCE INC
For the three and six months ended June 30, 2019, 557 thousand and 538 thousand common stock equivalents were included in the diluted WASO, respectively. For the three and six months ended June 30, 2018, 473 thousand and 398 thousand common stock equivalents were included in the diluted WASO, respectively. For the thre...
[ { "currency_/_unit": "shares", "end_character": 53, "end_date_for_period": "2019-06-30", "label": "eps", "start_character": 50, "start_date_for_period": "2019-04-01", "value": 557000 }, { "currency_/_unit": "shares", "end_character": 70, "end_date_for_period": "2019-06-30...
10-Q
0000014846-19-000031
20190808150948
20190630
BRT Apartments Corp.
Basic earnings (loss) per share is determined by dividing net income (loss) applicable to common stockholders for the applicable period by the weighted average number of shares of common stock outstanding during such period. The Units are excluded from the basic earnings per share calculation, as they are not participa...
[ { "currency_/_unit": "shares", "end_character": 1159, "end_date_for_period": "2018-06-30", "label": "eps", "start_character": 1152, "start_date_for_period": "2018-01-01", "value": 200000 } ]
10-Q
0001564590-19-028387
20190802162147
20190630
NAVIGANT CONSULTING INC
Managed services revenue for the three and six months ended June 30, 2019 was $60.6 million and $117.4 million, respectively and was $31.9 million and $63.3 million for the three and six months ended June 30, 2018.  Managed services made up 31% of total revenue before reimbursements for both the three and six months en...
[ { "currency_/_unit": "USD", "end_character": 83, "end_date_for_period": "2019-06-30", "label": "revenues", "start_character": 79, "start_date_for_period": "2019-04-01", "value": 60600000 }, { "currency_/_unit": "USD", "end_character": 102, "end_date_for_period": "2019-06-...
10-Q
0001104506-19-000020
20190801073323
20190630
INSMED Inc
The Company had $601.3 million in cash and cash equivalents as of June 30, 2019 and reported a net loss of $140.7 million for the six months ended June 30, 2019. Historically, the Company has funded its operations through public offerings of equity securities and debt financings. The Company commenced commercial shipme...
[ { "currency_/_unit": "USD", "end_character": 22, "end_date_for_period": "2019-06-30", "label": "XBRL-OOS", "start_character": 17, "start_date_for_period": "2019-06-30", "value": 601300000 }, { "currency_/_unit": "USD", "end_character": 113, "end_date_for_period": "2019-06...
10-Q
0000350797-19-000036
20190906151630
20190731
EATON VANCE CORP
13.4 million for the three and nine months ended July 31, 2018, respectively, as a result of this change. Lastly, contingent deferred sales charges received, which were previously recorded as a reduction of deferred sales commission assets, are now being recorded as revenue within the distribution and underwriting fees...
[ { "currency_/_unit": "USD", "end_character": 4, "end_date_for_period": "2018-07-31", "label": "revenues", "start_character": 0, "start_date_for_period": "2017-11-01", "value": 13400000 } ]
10-Q
0001735828-19-000029
20190809082130
20190630
Legacy Reserves Inc.
For the six months ended June 30, 2019 and 2018 we recorded income/(loss) before income taxes of $(141,148) and $14,290 respectively. All of Legacy's income is sourced within the United States. The effective combined U.S. federal and state income tax rates were 0.00% and 4.30% for the six months ended June 30, 2019 and...
[ { "currency_/_unit": "USD", "end_character": 106, "end_date_for_period": "2019-06-30", "label": "earnings", "start_character": 99, "start_date_for_period": "2019-01-01", "value": -141148000 }, { "currency_/_unit": "USD", "end_character": 119, "end_date_for_period": "2018-...
10-Q
0001171200-19-000278
20190726150523
20190630
ROLLINS INC
Clark Pest Control has a customer base of approximately 145,000 customers, which are served from 26 service locations in 2 states. Clark Pest Control recorded revenues of approximately $139.2 million for the fiscal year ended December 31, 2018. This acquisition will broaden Rollins' market share considerably. The Compa...
[ { "currency_/_unit": "USD", "end_character": 191, "end_date_for_period": "2018-12-31", "label": "revenues", "start_character": 186, "start_date_for_period": "2018-01-01", "value": 139200000 } ]
10-Q
0001486159-19-000032
20190809114034
20190630
Oasis Petroleum Inc.
The Company’s effective tax rate for the three and six months ended June 30, 2019 was 19.3% on a pre-tax income of $63.4 million and (17.7)% on a pre-tax loss of $48.3 million, respectively, as compared to an effective tax rate of 24.2% on a pre-tax loss of $417.3 million and 24.3% on a pre-tax loss of $412.8 million f...
[ { "currency_/_unit": "pure", "end_character": 90, "end_date_for_period": "2019-06-30", "label": "XBRL-OOS", "start_character": 86, "start_date_for_period": "2019-04-01", "value": 0.193 }, { "currency_/_unit": "USD", "end_character": 120, "end_date_for_period": "2019-06-30...
10-Q
0000109380-19-000179
20190806171145
20190630
ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/
The Bank enters into certain lease agreements where it is the lessor of real estate. Real estate leases are made from bank-owned and subleased property to generate cash flow from the property, including from leasing vacant suites in which the Bank occupies portions of the building. Operating lease income was $3 million...
[ { "currency_/_unit": "USD", "end_character": 312, "end_date_for_period": "2019-06-30", "label": "revenues", "start_character": 311, "start_date_for_period": "2019-04-01", "value": 3000000 }, { "currency_/_unit": "USD", "end_character": 374, "end_date_for_period": "2019-06...
10-Q
0001084991-19-000050
20190807105704
20190630
NATURAL GAS SERVICES GROUP INC
From time to time, upon the customer’s written request, we recognize revenue when manufacturing is complete and the equipment is ready for shipment. At the customer’s request, we will bill the customer upon completing all performance obligations, but before shipment. The customer will formally request that we ship the ...
[ { "currency_/_unit": "USD", "end_character": 1168, "end_date_for_period": "2019-06-30", "label": "revenues", "start_character": 1165, "start_date_for_period": "2019-01-01", "value": 6100000 } ]
10-Q
0001628280-19-010279
20190807160310
20190630
Teligent, Inc.
For the three months ended June 30, 2019, domestic net revenues were $13.4 million and foreign net revenues were $4.9 million. For the six months ended June 30, 2019, domestic net revenues were $23.1 million and foreign net revenues were $8.4 million. As of June 30, 2019, domestic assets were $138.4 million and foreign...
[ { "currency_/_unit": "USD", "end_character": 74, "end_date_for_period": "2019-06-30", "label": "revenues", "start_character": 70, "start_date_for_period": "2019-04-01", "value": 13400000 }, { "currency_/_unit": "USD", "end_character": 117, "end_date_for_period": "2019-06-...
10-Q
0001336917-19-000052
20190801165148
20190630
Under Armour, Inc.
In addition to the investment in Dome, the Company has a license agreement with Dome. The Company recorded license revenues from Dome of $5.2 million and $4.8 million for the three months ended June 30, 2019 and 2018, respectively, and $11.7 million and $13.7 million for the six months ended June 30, 2019 and 2018, res...
[ { "currency_/_unit": "USD", "end_character": 141, "end_date_for_period": "2019-06-30", "label": "revenues", "start_character": 138, "start_date_for_period": "2019-04-01", "value": 5200000 }, { "currency_/_unit": "USD", "end_character": 158, "end_date_for_period": "2018-06...
10-Q
0001647088-19-000036
20190802114535
20190802
WillScot Corp
Includes $4.1 million and $2.6 million of VAPS service revenue for the three months ended June 2019 and 2018, respectively, and $7.9 million and $4.9 million of VAPS service revenue for the six months ended June 30, 2019 and 2018, respectively.
[ { "currency_/_unit": "USD", "end_character": 13, "end_date_for_period": "2018-06-30", "label": "revenues", "start_character": 10, "start_date_for_period": "2018-04-01", "value": 4099999.9999999995 }, { "currency_/_unit": "USD", "end_character": 30, "end_date_for_period": ...
10-Q
0001125345-19-000098
20190731160959
20190630
MACROGENICS INC
The Company also has an agreement with Incyte, which was entered into in 2018, under which the Company is to perform development and manufacturing services for Incyte’s clinical needs of MGA012. The Company evaluated the agreement under ASC 606 and identified one performance obligation under the agreement: to perform ...
[ { "currency_/_unit": "USD", "end_character": 825, "end_date_for_period": "2019-06-30", "label": "revenues", "start_character": 822, "start_date_for_period": "2019-04-01", "value": 4200000 }, { "currency_/_unit": "USD", "end_character": 842, "end_date_for_period": "2018-06...
10-Q
0001125345-19-000098
20190731160959
20190630
MACROGENICS INC
Revenue associated with each performance obligation was recognized as the research and development services were provided using a cost-based input method according to research and development costs incurred to date compared to estimated total research and development costs. The transfer of control occurred over this ti...
[ { "currency_/_unit": "USD", "end_character": 660, "end_date_for_period": "2018-06-30", "label": "revenues", "start_character": 657, "start_date_for_period": "2018-04-01", "value": 400000 }, { "currency_/_unit": "USD", "end_character": 677, "end_date_for_period": "2018-06-...
10-Q
0001125920-19-000022
20190807171756
20190630
SHUTTERFLY INC
With respect to the convertible senior notes issued in 2013 and settled in cash upon their maturity in May 2018, the weighted-average impact to dilution for the period that the conversion option was outstanding was 660,000 shares and 690,000 shares for the three and six months ended June 30, 2018, respectively. The pot...
[ { "currency_/_unit": "shares", "end_character": 222, "end_date_for_period": "2018-06-30", "label": "eps", "start_character": 215, "start_date_for_period": "2018-04-01", "value": 660000 }, { "currency_/_unit": "shares", "end_character": 241, "end_date_for_period": "2018-06...
10-Q
0000930420-19-000238
20191031165804
20190930
KFORCE INC
Basic earnings per share is computed as net income divided by the weighted average number of common shares outstanding (“WASO”) during the period. WASO excludes unvested shares of restricted stock. Diluted earnings per share is computed by dividing net income by diluted WASO. Diluted WASO includes the dilutive effect o...
[ { "currency_/_unit": "shares", "end_character": 575, "end_date_for_period": "2019-09-30", "label": "eps", "start_character": 572, "start_date_for_period": "2019-07-01", "value": 572000 }, { "currency_/_unit": "shares", "end_character": 592, "end_date_for_period": "2019-09...
10-Q
0001596783-19-000205
20191105083839
20190930
Catalent, Inc.
The Company recorded a benefit for income taxes for the three months ended September 30, 2019 of $6.9 million relative to losses from operations before income taxes of $6.8 million. The amount of this benefit is primarily driven by U.S. income tax deductions, also referred to as a windfall benefit, related to the Compa...
[ { "currency_/_unit": "USD", "end_character": 101, "end_date_for_period": "2019-09-30", "label": "XBRL-OOS", "start_character": 98, "start_date_for_period": "2019-07-01", "value": -6900000 }, { "currency_/_unit": "USD", "end_character": 172, "end_date_for_period": "2019-09...
10-Q
0000005272-19-000054
20191101101451
20190930
AMERICAN INTERNATIONAL GROUP INC
138 million, respectively, and decreased Income from continuing operations before income tax expense by $
[ { "currency_/_unit": "USD", "end_character": 3, "end_date_for_period": "2019-09-30", "label": "earnings", "start_character": 0, "start_date_for_period": "2019-01-01", "value": -138000000 } ]
10-Q
0000005272-19-000054
20191101101451
20190930
AMERICAN INTERNATIONAL GROUP INC
170 million, respectively. The out of period adjustments for the three-month period are primarily related to increases in policyholder benefits and losses incurred reflecting updated actuarial assumptions.
[ { "currency_/_unit": "USD", "end_character": 3, "end_date_for_period": "2019-09-30", "label": "earnings", "start_character": 0, "start_date_for_period": "2019-01-01", "value": -170000000 } ]
10-Q
0001654151-19-000004
20191104171603
20190930
Deciphera Pharmaceuticals, Inc.
The accompanying consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business. Since inception, the Company has incurred recurring losses including net losses of $125.0 million ...
[ { "currency_/_unit": "USD", "end_character": 311, "end_date_for_period": "2019-09-30", "label": "earnings", "start_character": 306, "start_date_for_period": "2019-01-01", "value": -125000000 }, { "currency_/_unit": "USD", "end_character": 329, "end_date_for_period": "2018...
10-Q
0001654948-19-000062
20191113185917
20190930
Hartman vREIT XXI, Inc.
For the three months ended September 30, 2019 and 2018, the Company had net loss of $539,544 and $592,719, respectively. For the nine months ended September 30, 2019 and 2018, the Company incurred a net loss of $1,447,359 and $959,054, respectively. The Company does not anticipate forming any taxable REIT subsidiaries...
[ { "currency_/_unit": "USD", "end_character": 92, "end_date_for_period": "2019-09-30", "label": "earnings", "start_character": 85, "start_date_for_period": "2019-07-01", "value": -539544 }, { "currency_/_unit": "USD", "end_character": 105, "end_date_for_period": "2018-09-3...
10-Q
0001628280-19-012816
20191030161320
20190930
Kaleido Biosciences, Inc.
During the nine months ended September 30, 2019, operating activities used $60,149 of cash, due to our net loss of $66,819, partially offset by non-cash charges of $8,586 and net cash used by changes in our operating assets and liabilities of $1,916. Net cash provided by changes in our operating assets and liabilities ...
[ { "currency_/_unit": "USD", "end_character": 82, "end_date_for_period": "2019-09-30", "label": "XBRL-OOS", "start_character": 76, "start_date_for_period": "2019-01-01", "value": -60149000 }, { "currency_/_unit": "USD", "end_character": 122, "end_date_for_period": "2019-09...
10-Q
0001628280-19-012816
20191030161320
20190930
Kaleido Biosciences, Inc.
We are a clinical stage healthcare company with a limited operating history. Investment in product development in the healthcare industry, including of biopharmaceutical products, is highly speculative because it entails substantial upfront capital expenditures and significant risk that any potential product candidate ...
[ { "currency_/_unit": "USD", "end_character": 993, "end_date_for_period": "2019-09-30", "label": "earnings", "start_character": 987, "start_date_for_period": "2019-01-01", "value": -66819000 } ]
10-Q
0000109380-19-000207
20191105161651
20190930
ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/
The Bank enters into certain lease agreements where it is the lessor of real estate. Real estate leases are made from bank-owned and subleased property to generate cash flow from the property, including from leasing vacant suites in which the Bank occupies portions of the building. Operating lease income was $3 million...
[ { "currency_/_unit": "USD", "end_character": 356, "end_date_for_period": "2019-09-30", "label": "revenues", "start_character": 355, "start_date_for_period": "2019-01-01", "value": 9000000 }, { "currency_/_unit": "USD", "end_character": 365, "end_date_for_period": "2018-09...
10-Q
0001171200-19-000351
20191025153545
20190930
ROLLINS INC
Clark Pest Control has a customer base of approximately 145,000 customers, which are served from 26 service locations in 2 states. Clark Pest Control recorded revenues of approximately $139.2 million for the fiscal year ended December 31, 2018. The Company's consolidated statements of income include the results of oper...
[ { "currency_/_unit": "USD", "end_character": 191, "end_date_for_period": "2018-12-31", "label": "revenues", "start_character": 186, "start_date_for_period": "2018-01-01", "value": 139200000 } ]
10-Q
0001084991-19-000060
20191108160356
20190930
NATURAL GAS SERVICES GROUP INC
From time to time, upon the customer’s written request, we recognize revenue when manufacturing is complete and the equipment is ready for shipment. At the customer’s request, we will bill the customer upon completing all performance obligations, but before shipment. The customer will formally request that we ship the ...
[ { "currency_/_unit": "USD", "end_character": 1174, "end_date_for_period": "2019-09-30", "label": "revenues", "start_character": 1171, "start_date_for_period": "2019-01-01", "value": 9400000 } ]
10-Q
0001610950-19-000050
20191030185910
20190930
Syneos Health, Inc.
For the three and nine months ended September 30, 2019, the Company recorded income tax expense of $11.1 million and $43.8 million, respectively, compared to pre-tax income of $70.0 million and $84.0 million, respectively. The effective tax rate for the three and nine months ended September 30, 2019 varied from the U.S...
[ { "currency_/_unit": "USD", "end_character": 104, "end_date_for_period": "2019-09-30", "label": "XBRL-OOS", "start_character": 100, "start_date_for_period": "2019-07-01", "value": 11100000 }, { "currency_/_unit": "USD", "end_character": 122, "end_date_for_period": "2019-0...
10-Q
0001610950-19-000050
20191030185910
20190930
Syneos Health, Inc.
For the three and nine months ended September 30, 2018, the Company recorded an income tax expense of $12.0 million and $19.1 million, respectively, compared to pre-tax income of $1.6 million and pre-tax loss of $2.3 million, respectively. The effective tax rate for the three and nine months ended September 30, 2018 va...
[ { "currency_/_unit": "USD", "end_character": 107, "end_date_for_period": "2018-09-30", "label": "XBRL-OOS", "start_character": 103, "start_date_for_period": "2018-07-01", "value": 12000000 }, { "currency_/_unit": "USD", "end_character": 125, "end_date_for_period": "2018-0...
10-Q
0001005011-19-000018
20191022145005
20190930
GRAPHIC PACKAGING INTERNATIONAL, LLC
The year over year Net Sales and Loss from Operations impact for Letica Foodservice, PFP and Artistic acquisitions were $96.0 million and $8.3 million, respectively.
[ { "currency_/_unit": "USD", "end_character": 125, "end_date_for_period": "2019-09-30", "label": "XBRL-OOS", "start_character": 121, "start_date_for_period": "2019-01-01", "value": 96000000 }, { "currency_/_unit": "USD", "end_character": 142, "end_date_for_period": "2019-0...
10-Q
0001005011-19-000018
20191022145005
20190930
GRAPHIC PACKAGING INTERNATIONAL, LLC
Net Sales for the three months ended September 30, 2019, increased $49.8 million or 3.3% to $1,581.6 million from $1,531.8 million for the three months ended September 30, 2018, due to higher selling prices, volume growth, and the Artistic and 2018 Acquisitions discussed below, partially offset by unfavorable foreign c...
[ { "currency_/_unit": "USD", "end_character": 100, "end_date_for_period": "2019-09-30", "label": "revenues", "start_character": 93, "start_date_for_period": "2019-07-01", "value": 1581600000 }, { "currency_/_unit": "USD", "end_character": 122, "end_date_for_period": "2018-...
10-Q
0001005011-19-000018
20191022145005
20190930
GRAPHIC PACKAGING INTERNATIONAL, LLC
Income from Operations for the three months ended September 30, 2019 decreased $43.7 million or 26.2% to $122.9 million from $166.6 million for the three months ended September 30, 2018 due to the gain on sale of assets in 2018, lower net performance, higher inflation and unfavorable foreign currency exchange rates, pa...
[ { "currency_/_unit": "USD", "end_character": 111, "end_date_for_period": "2019-09-30", "label": "ebit", "start_character": 106, "start_date_for_period": "2019-07-01", "value": 122900000 }, { "currency_/_unit": "USD", "end_character": 131, "end_date_for_period": "2018-09-3...
10-Q
0001005011-19-000018
20191022145005
20190930
GRAPHIC PACKAGING INTERNATIONAL, LLC
The Company’s Net Sales for the three months ended September 30, 2019 increased by $49.8 million or 3.3% to $1,581.6 million from $1,531.8 million for the three months ended September 30, 2018, due to Net Sales of $34.7 million from the Artistic and 2018 Acquisitions, higher selling prices and volume growth. These incr...
[ { "currency_/_unit": "USD", "end_character": 116, "end_date_for_period": "2019-09-30", "label": "revenues", "start_character": 109, "start_date_for_period": "2019-07-01", "value": 1581600000 }, { "currency_/_unit": "USD", "end_character": 138, "end_date_for_period": "2018...
10-Q
0001005011-19-000018
20191022145005
20190930
GRAPHIC PACKAGING INTERNATIONAL, LLC
Income from Operations for the three months ended September 30, 2019 decreased $43.7 million or 26.2% to $122.9 million from $166.6 million for the three months ended September 30, 2018 due to the 2018 gain of $37.1 million from the sale of the Santa Clara mill site, higher inflation, start-up costs associated with the...
[ { "currency_/_unit": "USD", "end_character": 111, "end_date_for_period": "2019-09-30", "label": "ebit", "start_character": 106, "start_date_for_period": "2019-07-01", "value": 122900000 }, { "currency_/_unit": "USD", "end_character": 131, "end_date_for_period": "2018-09-3...
10-Q
0001005011-19-000018
20191022145005
20190930
GRAPHIC PACKAGING INTERNATIONAL, LLC
During the three months ended September 30, 2019, the Company recognized Income Tax Expense of $3.6 million on Income before Income Taxes and Equity Income of Unconsolidated Entity of $87.0 million. The Company is classified as a disregarded entity for U.S. income tax purposes and is generally not subject to domestic i...
[ { "currency_/_unit": "USD", "end_character": 99, "end_date_for_period": "2019-09-30", "label": "XBRL-OOS", "start_character": 96, "start_date_for_period": "2019-07-01", "value": 3600000 }, { "currency_/_unit": "USD", "end_character": 189, "end_date_for_period": "2019-09-3...
10-Q
0001005011-19-000018
20191022145005
20190930
GRAPHIC PACKAGING INTERNATIONAL, LLC
During the three months ended September 30, 2018, the Company recognized Income Tax Expense of $4.6 million on Income before Income Taxes and Equity Income of Unconsolidated Entity of $139.7 million.
[ { "currency_/_unit": "USD", "end_character": 99, "end_date_for_period": "2018-09-30", "label": "XBRL-OOS", "start_character": 96, "start_date_for_period": "2018-07-01", "value": 4600000 }, { "currency_/_unit": "USD", "end_character": 190, "end_date_for_period": "2018-09-3...
10-Q
0001005011-19-000018
20191022145005
20190930
GRAPHIC PACKAGING INTERNATIONAL, LLC
The Company’s Net Sales for the nine months ended September 30, 2019 increased by $120.2 million or 2.7% to $4,640.3 million from $4,520.1 million for the nine months ended September 30, 2018, due to higher selling prices and Net Sales of $96.0 million from the Artistic and 2018 Acquisitions. These increases were parti...
[ { "currency_/_unit": "USD", "end_character": 116, "end_date_for_period": "2019-09-30", "label": "revenues", "start_character": 109, "start_date_for_period": "2019-01-01", "value": 4640300000 }, { "currency_/_unit": "USD", "end_character": 138, "end_date_for_period": "2018...
10-Q
0001005011-19-000018
20191022145005
20190930
GRAPHIC PACKAGING INTERNATIONAL, LLC
Income from Operations for the nine months ended September 30, 2019 increased $33.6 million or 9.1% to $401.5 million from $367.9 million for the nine months ended September 30, 2018 due to the higher selling prices, cost savings through continuous improvement programs, benefits from completed capital projects and syne...
[ { "currency_/_unit": "USD", "end_character": 109, "end_date_for_period": "2019-09-30", "label": "ebit", "start_character": 104, "start_date_for_period": "2019-01-01", "value": 401500000 }, { "currency_/_unit": "USD", "end_character": 129, "end_date_for_period": "2018-09-3...
10-Q
0001005011-19-000018
20191022145005
20190930
GRAPHIC PACKAGING INTERNATIONAL, LLC
During the nine months ended September 30, 2019, the Company recognized Income Tax Expense of $12.3 million on Income before Income Taxes and Equity Income of Unconsolidated Entity of $295.0 million. The Company is classified as a disregarded entity for U.S. income tax purposes and is generally not subject to domestic ...
[ { "currency_/_unit": "USD", "end_character": 99, "end_date_for_period": "2019-09-30", "label": "XBRL-OOS", "start_character": 95, "start_date_for_period": "2019-01-01", "value": 12300000 }, { "currency_/_unit": "USD", "end_character": 190, "end_date_for_period": "2019-09-...
10-Q
0001005011-19-000018
20191022145005
20190930
GRAPHIC PACKAGING INTERNATIONAL, LLC
During the nine months ended September 30, 2018, the Company recognized Income Tax Expense of $10.4 million on Income before Income Taxes and Equity Income of Unconsolidated Entity of $288.3 million.
[ { "currency_/_unit": "USD", "end_character": 99, "end_date_for_period": "2018-09-30", "label": "XBRL-OOS", "start_character": 95, "start_date_for_period": "2018-01-01", "value": 10400000 }, { "currency_/_unit": "USD", "end_character": 190, "end_date_for_period": "2018-09-...
10-Q
0001548187-19-000006
20191107162826
20190930
Soliton, Inc.
For the three and nine months ended September 30, 2019 and 2018, the Company incurred net losses of $4,294,897 and $2,978,621, respectively, and $10,476,776 and $6,895,374, respectively, and for the nine months ended September 30, 2019 and 2018, had net cash flows used in operating activities of $9,033,513 and $3,726,3...
[ { "currency_/_unit": "USD", "end_character": 110, "end_date_for_period": "2019-09-30", "label": "earnings", "start_character": 101, "start_date_for_period": "2019-07-01", "value": -4294897 }, { "currency_/_unit": "USD", "end_character": 125, "end_date_for_period": "2018-0...
10-Q
0001094285-19-000162
20191025195204
20190929
TELEDYNE TECHNOLOGIES INC
Selling, general and administrative expenses, including research and development and bid and proposal expense, increased $12.2 million in the third quarter of 2019 and primarily reflected the impact of higher sales. Selling, general and administrative expenses for the third quarter of 2019, as a percentage of net sale...
[ { "currency_/_unit": "USD", "end_character": 458, "end_date_for_period": "2019-09-29", "label": "ebit", "start_character": 454, "start_date_for_period": "2019-07-01", "value": -14600000 } ]
10-Q
0001062993-19-004184
20191106164805
20190928
SunOpta Inc.
(4) Comprises fruit snack offerings, as well as the sale of flexible resealable pouch and nutrition bar products in the third quarter and first three quarters of 2018 of $0.0 million and $3.1 million, respectively. The Company exited the flexible resealable pouch and nutrition bar product lines and operations in the fo...
[ { "currency_/_unit": "USD", "end_character": 175, "end_date_for_period": "2018-09-29", "label": "revenues", "start_character": 171, "start_date_for_period": "2018-07-01", "value": 0 }, { "currency_/_unit": "USD", "end_character": 191, "end_date_for_period": "2018-09-29", ...
10-Q
0001062993-19-004184
20191106164805
20190928
SunOpta Inc.
(4) Comprises fruit snack offerings, as well as the sale of flexible resealable pouch and nutrition bar products in the third quarter and first three quarters of 2018 of $0.0 million and $3.1 million, respectively. The Company exited the flexible resealable pouch and nutrition bar product lines and operations in the fo...
[ { "currency_/_unit": "USD", "end_character": 175, "end_date_for_period": "2018-09-29", "label": "revenues", "start_character": 171, "start_date_for_period": "2018-07-01", "value": 0 }, { "currency_/_unit": "USD", "end_character": 191, "end_date_for_period": "2018-09-29", ...
10-Q
0001125345-19-000112
20191106160806
20190930
MACROGENICS INC
The Company recognized the $150.0 million allocated to the license when it satisfied its performance obligation and transferred the license to Incyte in 2017. The $4.0 million allocated to the clinical activities was recognized over the period from the effective date of the agreement until such time as the clinical ac...
[ { "currency_/_unit": "USD", "end_character": 33, "end_date_for_period": "2017-10-31", "label": "revenues", "start_character": 28, "start_date_for_period": "2017-10-01", "value": 150000000 }, { "currency_/_unit": "USD", "end_character": 168, "end_date_for_period": "2017-10...
End of preview. Expand in Data Studio

HiFi-KPI Lite: Expert-Curated Financial KPI Extraction

Dataset Summary

HiFi-KPI Lite is a manually curated subset of the HiFi-KPI dataset, designed for evaluating structured financial KPI extraction. Unlike the full HiFi-KPI dataset, HiFi-KPI Lite maps financial entities to a much reduced, expert-defined label space. The dataset consists of ∼8K paragraphs and ∼25K entities, making it suitable for rapid model evaluation.

Supported Tasks

The dataset is optimized for:

  • Named Entity Recognition (NER): Identifying financial KPIs from text.
  • Structured Data Extraction: Extracting numerical values, currencies, and corresponding time periods from financial statements.
  • Text Classification: Associating financial statements with expert-mapped KPI labels.

Languages

The dataset is in English, sourced from SEC 10-K and 10-Q filings.

Dataset Structure

Data Fields

Each entry in HiFi-KPI Lite includes:

  • form_type: "10-K" or "10-Q"
  • accession_number: Unique filing identifier
  • filing_date: Timestamp of the filing
  • company_name: Name of the reporting entity
  • text: Extracted paragraph from the filing
  • entities (list of extracted entities):
    • label: Expert-defined financial KPI category(Ebit, revnues ..)
    • start_date_for_period / end_date_for_period: Time period of the financial figure
    • currency/unit: Currency (e.g., USD, EUR)
    • value: Extracted numerical figure

Dataset Statistics

Split # Paragraphs # Entities
Train 6,359 19,749
Dev 768 2,601
Test 856 2,437

Baseline Model Performance

We establish baselines using:

  • Sequence Labeling: fine-tuning BERT (bert-base-uncased) with a token classification head.
  • LLM-based Structured Extraction: Few-shot prompting for NuExtract, Qwen-2.5-14B, and DeepSeek-V3.

Macro F1 Performance on HiFi-KPI Lite

Model Precision Recall Micro F1
BERT (SL) 89.2 91.8 89.1
Qwen-2.5-14B 63.7 60.2 49.5
DeepSeek-V3 67.8 65.9 46.4

Uses and Applications

HiFi-KPI Lite is useful for:

  • Benchmarking KPI Extraction: Evaluating model performance on structured financial data extraction.
  • Fine-Grained Financial NLP Tasks: Training models on structured financial entity recognition.
  • Evaluation of Large Language Models (LLMs): Testing how well LLMs generalize to financial entity extraction.

Citation

If you use HiFi-KPI Lite in your research, please cite:

@article{aavang2025hifi,
  title={HiFi-KPI: A Dataset for Hierarchical KPI Extraction from Earnings Filings},
  author={Aavang, Rasmus and Rizzi, Giovanni and Bøggild, Rasmus and Iolov, Alexandre and Zhang, Mike and Bjerva, Johannes},
  journal={arXiv preprint arXiv:2502.15411},
  year={2025}
}

Access

Example code and repo with links to all models at GitHub Repository

Downloads last month
67

Models trained or fine-tuned on AAU-NLP/hifi-kpi-lite

Paper for AAU-NLP/hifi-kpi-lite